Three Questions Every Executive Should Ask Before Investing in Another Wellness Benefit

The wellness benefits category now represents one of the fastest-growing lines in most corporate HR budgets. Mental health platforms. Meditation apps. Expanded EAPs. Burnout prevention tools. Executive health programs. Lifestyle reimbursements. The menu is enormous and growing. The marketing materials are polished. The ROI projections are confident.

The outcomes, in most organizations, are flat.

Before your organization writes another check for another wellness benefit, I would ask you to apply three diagnostic questions to the decision. These are the questions I would ask on behalf of your workforce, and the questions a clinically rigorous executive should be asking on behalf of the P&L.

The first question is this. What specifically does this intervention address, and what is the clinical or structural pathway by which it addresses it?

If the answer is vague, that is diagnostic information. If the vendor cannot articulate specifically what physiological, behavioral, or structural outcome their offering is designed to change, and the mechanism by which it does so, you are being sold a signal rather than a strategy. Mental health platforms that broadly offer counseling are useful when a person seeks them out, but they are not addressing the conditions that produce the need in the first place. Meditation apps may support general wellbeing for the people who use them, but their relationship to specific workplace stressors is diffuse at best. A clear vendor should be able to tell you, specifically, what they are changing and how.

The second question is this. What are we measuring, and over what timeline?

Most wellness vendors offer utilization metrics as their primary measure of success. Utilization tells you whether people are logging in. It does not tell you whether anything has changed. The outcomes that matter to your organization are retention of key talent, performance of key teams, absence patterns, healthcare cost trends, and leading indicators of burnout like engagement decline, missed deadlines, and interpersonal breakdowns. If the vendor is not able to help you measure any of those outcomes, or is unwilling to be measured against them over a reasonable timeline, you are investing in a program that cannot be held accountable for whether it actually works. Fifteen percent utilization on an unmeasured intervention is not a win. It is an unmeasured intervention.

The third question is this. What is the implementation reality in the workflow of the people who are supposed to benefit?

I have watched companies invest in wellness benefits that require their most burned-out employees to add an hour of self-care activity to a day that already has no margin. The intervention cannot work because the condition it is addressing is the one that prevents its use. If your workforce does not have the time, cognitive bandwidth, or psychological permission to access a benefit, that benefit will not change anything regardless of its clinical merit. Any serious wellness investment should include a clear-eyed assessment of whether the people who most need it will realistically be able to use it, and what the organization will do structurally to make that use possible. Without that assessment, you are funding an offering that will primarily be used by the employees who need it least.

These three questions cut through most of the noise in the wellness category. They force vendors to be specific about what they are selling. They force your organization to be specific about what it is buying. And they orient the entire conversation around whether the investment is actually likely to produce the outcomes your business needs.

A workplace wellness strategy worth the budget line should be able to answer all three questions clearly. If it cannot, you have not identified a strategy. You have identified another benefit that will take its place in a list of visible investments while your metrics continue to flat-line.

The real work of workplace wellness is strategic, clinical, and measurable. It is also achievable, with the right diagnostic lens applied to the decisions your organization is already making. These three questions are the beginning of that lens.